204 related articles for article (PubMed ID: 22971141)
1. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.
Topic A; Stankovic M; Divac-Rankov A; Petrovic-Stanojevic N; Mitic-Milikic M; Nagorni-Obradovic L; Radojkovic D
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1282-6. PubMed ID: 22971141
[TBL] [Abstract][Full Text] [Related]
2. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
Al Ashry HS; Strange C
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
[TBL] [Abstract][Full Text] [Related]
3. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
de Serres FJ; Blanco I; Fernández-Bustillo E
COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
[TBL] [Abstract][Full Text] [Related]
4. [The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in population of Central Poland--preliminary results from newborn screening].
Chorostowska-Wynimko J; Struniawski R; Popławska B; Borszewska-Kornacka M
Pneumonol Alergol Pol; 2012; 80(5):450-3. PubMed ID: 22926906
[TBL] [Abstract][Full Text] [Related]
5. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
[TBL] [Abstract][Full Text] [Related]
6. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary langerhans cell histiocytosis - insight into the incidence of alfa-1-antitrypsin (A1ATD) deficiency alleles.
Radzikowska E; Struniawski R; Chorostowska-Wynimko J; Wiatr E; Roszkowski-Śliż K
Adv Respir Med; 2017; 85(6):297-300. PubMed ID: 29288477
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
[TBL] [Abstract][Full Text] [Related]
9. Asthma and allergy in alpha-1 antitrypsin deficiency.
Eden E; Strange C; Holladay B; Xie L
Respir Med; 2006 Aug; 100(8):1384-91. PubMed ID: 16403617
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in α-1-antitrypsin deficiency-related lung disease.
Brebner JA; Stockley RA
Expert Rev Respir Med; 2013 Jun; 7(3):213-29; quiz 230. PubMed ID: 23734645
[TBL] [Abstract][Full Text] [Related]
11. α1-Antitrypsin deficiency.
Greene CM; Marciniak SJ; Teckman J; Ferrarotti I; Brantly ML; Lomas DA; Stoller JK; McElvaney NG
Nat Rev Dis Primers; 2016 Jul; 2():16051. PubMed ID: 27465791
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Rare Alpha-1 Antitrypsin Variants in Polish Patients with Chronic Respiratory Disorders.
Duk K; Zdral A; Szumna B; Roży A; Chorostowska-Wynimko J
Adv Exp Med Biol; 2016; 910():47-53. PubMed ID: 26987331
[TBL] [Abstract][Full Text] [Related]
13. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.
Stockley RA; Pye A; De Soyza J; Turner AM; Miravitlles M;
Orphanet J Rare Dis; 2023 Aug; 18(1):243. PubMed ID: 37573351
[TBL] [Abstract][Full Text] [Related]
15. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
Kueppers F
Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
[TBL] [Abstract][Full Text] [Related]
16. [PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain].
Blanco I; Fernández-Bustillo E; de Serres FJ; Alkassam D; Rodríguez Menéndez C
Med Clin (Barc); 2004 Dec; 123(20):761-5. PubMed ID: 15607066
[TBL] [Abstract][Full Text] [Related]
17. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
Corda L; Medicina D; La Piana GE; Bertella E; Moretti G; Bianchi L; Pinelli V; Savoldi G; Baiardi P; Facchetti F; Gatta N; Annesi-Maesano I; Balbi B
Respiration; 2011; 82(5):418-25. PubMed ID: 21474916
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.
Santangelo S; Scarlata S; Poeta ML; Bialas AJ; Paone G; Incalzi RA
Curr Med Chem; 2017; 24(1):65-90. PubMed ID: 27855621
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of alpha-1-antitrypsin phenotypes and genotypes in patients with early-onset pulmonary emphysema].
Dwomiczak S; Ziora D; Konofalski L; Szalaty M; Kowalska A; Kozielski J
Pneumonol Alergol Pol; 2005; 73(1):12-7. PubMed ID: 16539178
[TBL] [Abstract][Full Text] [Related]
20. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
